Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
If you experience any suspected side effects, report them to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Weight Loss Results: Head-to-Head Data Semaglutide Clinical Trial Results The STEP (Semaglutide Treatment Effect in People with Obesity) trial program is the most comprehensive dataset for any anti-obesity medication: STEP 1 (Wilding et al., 2021, NEJM ): 1,961 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Semaglutide 2.4 mg weekly vs
Our most recent reportwith data through June 2025showed increases in overall anti-obesity medication (AOM) prescribing and AOM tirzepatide and semaglutide compared to March 2025 ( 1 )
Clinical trials track predefined adverse events with strict reporting criteria
If your next scheduled dose is in less than 2 days (48 hours), you can skip the missed dose and continue with your regular dosing schedule
